• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性卵巢功能不全:临床与遗传学研究进展。

Primary ovarian insufficiency: update on clinical and genetic findings.

机构信息

Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.

Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.

出版信息

Front Endocrinol (Lausanne). 2024 Sep 26;15:1464803. doi: 10.3389/fendo.2024.1464803. eCollection 2024.

DOI:10.3389/fendo.2024.1464803
PMID:39391877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11466302/
Abstract

Primary ovarian insufficiency (POI) is a disorder of insufficient ovarian follicle function before the age of 40 years with an estimated prevalence of 3.7% worldwide. Its relevance is emerging due to the increasing number of women desiring conception late or beyond the third decade of their lives. POI clinical presentation is extremely heterogeneous with a possible exordium as primary amenorrhea due to ovarian dysgenesis or with a secondary amenorrhea due to different congenital or acquired abnormalities. POI significantly impacts non only on the fertility prospect of the affected women but also on their general, psychological, sexual quality of life, and, furthermore, on their long-term bone, cardiovascular, and cognitive health. In several cases the underlying cause of POI remains unknown and, thus, these forms are still classified as idiopathic. However, we now know the age of menopause is an inheritable trait and POI has a strong genetic background. This is confirmed by the existence of several candidate genes, experimental and natural models. The most common genetic contributors to POI are the X chromosome-linked defects. Moreover, the variable expressivity of POI defect suggests it can be considered as a multifactorial or oligogenic defect. Here, we present an updated review on clinical findings and on the principal X-linked and autosomal genes involved in syndromic and non-syndromic forms of POI. We also provide current information on the management of the premature hypoestrogenic state as well as on fertility preservation in subjects at risk of POI.

摘要

原发性卵巢功能不全 (POI) 是指 40 岁以前卵巢卵泡功能不足的一种疾病,全球估计患病率为 3.7%。由于越来越多的女性希望在生命的第三个十年以后怀孕,因此这种疾病的相关性正在显现。POI 的临床表现极其多样,可能由于卵巢发育不良而出现原发性闭经,也可能由于不同的先天性或后天性异常而出现继发性闭经。POI 不仅对受影响女性的生育前景有重大影响,而且对其整体、心理、性生活质量也有重大影响,此外,对其长期的骨骼、心血管和认知健康也有重大影响。在某些情况下,POI 的根本原因仍然未知,因此这些形式仍被归类为特发性。然而,我们现在知道绝经年龄是一种可遗传的特征,POI 具有很强的遗传背景。这一点得到了几个候选基因、实验和自然模型的证实。导致 POI 的最常见遗传因素是 X 染色体连锁缺陷。此外,POI 缺陷的可变性表达表明它可以被视为一种多因素或寡基因缺陷。在这里,我们对临床发现以及涉及综合征和非综合征形式的 POI 的主要 X 连锁和常染色体基因进行了更新综述。我们还提供了关于在 POI 风险人群中过早出现低雌激素状态的管理以及生育力保存的最新信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcf/11466302/670279908528/fendo-15-1464803-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcf/11466302/670279908528/fendo-15-1464803-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dcf/11466302/670279908528/fendo-15-1464803-g001.jpg

相似文献

1
Primary ovarian insufficiency: update on clinical and genetic findings.原发性卵巢功能不全:临床与遗传学研究进展。
Front Endocrinol (Lausanne). 2024 Sep 26;15:1464803. doi: 10.3389/fendo.2024.1464803. eCollection 2024.
2
Genetics of primary ovarian insufficiency.原发性卵巢功能不全的遗传学
Clin Genet. 2017 Feb;91(2):183-198. doi: 10.1111/cge.12921. Epub 2016 Dec 12.
3
Genes involved in human premature ovarian failure.涉及人类卵巢早衰的基因。
J Mol Endocrinol. 2010 Nov;45(5):257-79. doi: 10.1677/JME-10-0070. Epub 2010 Jul 28.
4
Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency.靶向全外显子测序和果蝇模型揭示原发性卵巢功能不全的分子基础。
Hum Reprod. 2021 Oct 18;36(11):2975-2991. doi: 10.1093/humrep/deab192.
5
Targeted Next-Generation Sequencing Indicates a Frequent Oligogenic Involvement in Primary Ovarian Insufficiency Onset.靶向新一代测序表明原发性卵巢功能不全发病中存在频繁的寡基因参与。
Front Endocrinol (Lausanne). 2021 Nov 4;12:664645. doi: 10.3389/fendo.2021.664645. eCollection 2021.
6
Genes involved in the pathogenesis of premature ovarian insufficiency.参与卵巢早衰发病机制的基因。
Minerva Ginecol. 2015 Oct;67(5):421-30. Epub 2015 Jun 26.
7
Association of genetic disorders and congenital malformations with premature ovarian insufficiency: a nationwide register-based study.遗传疾病和先天畸形与卵巢早衰的关联:一项全国范围内基于注册的研究。
Hum Reprod. 2023 Jun 1;38(6):1224-1230. doi: 10.1093/humrep/dead066.
8
Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI).遗传性疾病导致的卵巢早衰(POI)的生育力保存。
J Assist Reprod Genet. 2021 Apr;38(4):759-777. doi: 10.1007/s10815-021-02067-7. Epub 2021 Jan 25.
9
High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function.对 46,XX 早发性卵巢功能不全患者进行高分辨率 array-CGH 分析揭示了新的参与卵巢功能的基因。
Hum Reprod. 2019 Mar 1;34(3):574-583. doi: 10.1093/humrep/dey389.
10
Next-generation sequencing of 500 POI patients identified novel responsible monogenic and oligogenic variants.对 500 名 POI 患者进行下一代测序,鉴定出了新的单基因和寡基因责任变异体。
J Ovarian Res. 2023 Feb 15;16(1):39. doi: 10.1186/s13048-023-01104-6.

引用本文的文献

1
Premature ovarian insufficiency: Updated concepts in diagnosis and hormonal treatment strategies.卵巢早衰:诊断与激素治疗策略的最新概念
Clinics (Sao Paulo). 2025 Aug 20;80:100745. doi: 10.1016/j.clinsp.2025.100745.
2
Female germline stem cells: recent advances, opportunities, and challenges to overcome.雌性生殖系干细胞:最新进展、机遇及有待克服的挑战
Cell Regen. 2025 Aug 12;14(1):34. doi: 10.1186/s13619-025-00256-8.
3
Stage-specific autophagy dynamics in reproductive processes and associated disorders.生殖过程及相关疾病中的阶段特异性自噬动力学

本文引用的文献

1
Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism.英国内分泌学会女性性腺功能减退症诊治指南
Clin Endocrinol (Oxf). 2024 Nov;101(5):409-442. doi: 10.1111/cen.15097. Epub 2024 Jun 21.
2
Clinical practice guidelines for the care of girls and women with Turner syndrome.特纳综合征患者的护理临床实践指南。
Eur J Endocrinol. 2024 Jun 5;190(6):G53-G151. doi: 10.1093/ejendo/lvae050.
3
Managing menopause after cancer.癌症患者的更年期管理。
Front Cell Dev Biol. 2025 Jul 28;13:1639691. doi: 10.3389/fcell.2025.1639691. eCollection 2025.
4
Mesenchymal Stem Cells: A Therapeutic Approach in Fertility Restoration in Premature Ovarian Insufficiency.间充质干细胞:一种用于恢复卵巢早衰生育能力的治疗方法。
Stem Cell Rev Rep. 2025 Oct;21(7):2089-2102. doi: 10.1007/s12015-025-10944-2. Epub 2025 Aug 1.
5
Platelet-Rich Plasma Therapy in Premature Ovarian Insufficiency: A Case Series of IVF Outcomes.富血小板血浆疗法治疗卵巢早衰:体外受精结局的病例系列研究
Int Med Case Rep J. 2025 Jul 8;18:859-867. doi: 10.2147/IMCRJ.S527318. eCollection 2025.
6
Changing Etiological Spectrum of Premature Ovarian Insufficiency over the Past Decades: A Comparative Analysis of Two Cohorts from a Single Center.过去几十年卵巢早衰病因谱的变化:来自单一中心的两个队列的比较分析
Diagnostics (Basel). 2025 Jul 6;15(13):1724. doi: 10.3390/diagnostics15131724.
7
Identification of genetic variants in patients with primary and secondary amenorrhea.原发性和继发性闭经患者基因变异的鉴定。
Saudi Med J. 2025 Jun;46(6):659-669. doi: 10.15537/smj.2025.46.6.20250205.
8
Platelet-Rich Plasma (PRP) in Reproductive Medicine: A Critical Review of PRP Therapy in Low-Reserve and Premature Ovarian Insufficiency.富血小板血浆(PRP)在生殖医学中的应用:对低储备和卵巢早衰中PRP治疗的批判性综述
Biomedicines. 2025 May 21;13(5):1257. doi: 10.3390/biomedicines13051257.
9
LRRC4 Deficiency Drives Premature Ovarian Insufficiency by Disrupting Metabolic Homeostasis in Granulosa Cells.LRRC4基因缺陷通过破坏颗粒细胞代谢稳态导致卵巢早衰。
Adv Sci (Weinh). 2025 Jun;12(23):e2417717. doi: 10.1002/advs.202417717. Epub 2025 May 2.
10
Association Between Dietary Taste Preferences and Primary Ovarian Insufficiency: A Mendelian Randomization Study.饮食口味偏好与原发性卵巢功能不全之间的关联:一项孟德尔随机化研究。
Int J Womens Health. 2025 Apr 13;17:1039-1047. doi: 10.2147/IJWH.S505332. eCollection 2025.
Lancet. 2024 Mar 9;403(10430):984-996. doi: 10.1016/S0140-6736(23)02802-7. Epub 2024 Mar 5.
4
Optimising health after early menopause.绝经早期后的健康优化。
Lancet. 2024 Mar 9;403(10430):958-968. doi: 10.1016/S0140-6736(23)02800-3. Epub 2024 Mar 5.
5
Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency.干细胞治疗卵巢早衰不孕患者的现状与展望。
Biomolecules. 2024 Feb 19;14(2):242. doi: 10.3390/biom14020242.
6
Genitourinary symptoms and sexual function in women with primary ovarian insufficiency.原发性卵巢功能不全女性的泌尿生殖系统症状和性功能。
Climacteric. 2024 Jun;27(3):269-274. doi: 10.1080/13697137.2024.2306278. Epub 2024 Feb 3.
7
Bi-allelic missense variants in MEI4 cause preimplantation embryonic arrest and female infertility.MEI4 中的双等位基因突变导致着床前胚胎停滞和女性不孕。
Hum Genet. 2024 Oct;143(9-10):1049-1060. doi: 10.1007/s00439-023-02633-2. Epub 2024 Jan 22.
8
miRNA profiling of granulosa cell-derived exosomes reveals their role in promoting follicle development.颗粒细胞衍生的外泌体的 miRNA 谱分析揭示了它们在促进卵泡发育中的作用。
J Cell Physiol. 2024 Jan;239(1):20-35. doi: 10.1002/jcp.31140. Epub 2023 Dec 27.
9
Investigation of the molecular genetic causes of non-syndromic primary ovarian ınsufficiency by next generation sequencing analysis.采用下一代测序分析研究非综合征型原发性卵巢功能不全的分子遗传病因。
Arch Endocrinol Metab. 2023 Nov 17;68:e220475. doi: 10.20945/2359-4292-2022-0475.
10
Homozygous missense variant in MEIOSIN causes premature ovarian insufficiency.MEIOSIN 中的纯合错义变异导致卵巢早衰。
Hum Reprod. 2023 Nov 20;38(Suppl 2):ii47-ii56. doi: 10.1093/humrep/dead084.